HRP940411B1 - 1,5 -benzodiazepine derivatives - Google Patents

1,5 -benzodiazepine derivatives

Info

Publication number
HRP940411B1
HRP940411B1 HR940411A HRP940411A HRP940411B1 HR P940411 B1 HRP940411 B1 HR P940411B1 HR 940411 A HR940411 A HR 940411A HR P940411 A HRP940411 A HR P940411A HR P940411 B1 HRP940411 B1 HR P940411B1
Authority
HR
Croatia
Prior art keywords
benzodiazepine derivatives
benzodiazepine
derivatives
Prior art date
Application number
HR940411A
Other languages
English (en)
Inventor
Donati Daniele
Ursini Antonella
Corsi Mauro
Original Assignee
Glaxo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Spa filed Critical Glaxo Spa
Publication of HRP940411A2 publication Critical patent/HRP940411A2/hr
Publication of HRP940411B1 publication Critical patent/HRP940411B1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/121,5-Benzodiazepines; Hydrogenated 1,5-benzodiazepines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/582Recycling of unreacted starting or intermediate materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
HR940411A 1993-07-20 1994-07-18 1,5 -benzodiazepine derivatives HRP940411B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939314981A GB9314981D0 (en) 1993-07-20 1993-07-20 Chemical compounds

Publications (2)

Publication Number Publication Date
HRP940411A2 HRP940411A2 (en) 1997-04-30
HRP940411B1 true HRP940411B1 (en) 2000-12-31

Family

ID=10739096

Family Applications (1)

Application Number Title Priority Date Filing Date
HR940411A HRP940411B1 (en) 1993-07-20 1994-07-18 1,5 -benzodiazepine derivatives

Country Status (32)

Country Link
US (1) US5716953A (de)
EP (1) EP0710230B1 (de)
JP (1) JP3587849B2 (de)
KR (1) KR100347287B1 (de)
CN (1) CN1050835C (de)
AP (1) AP492A (de)
AT (1) ATE171167T1 (de)
AU (1) AU687858B2 (de)
CA (1) CA2167308A1 (de)
CO (1) CO4290299A1 (de)
CZ (1) CZ290472B6 (de)
DE (1) DE69413405T2 (de)
DK (1) DK0710230T3 (de)
EC (1) ECSP941120A (de)
ES (1) ES2123812T3 (de)
FI (1) FI960223A (de)
GB (1) GB9314981D0 (de)
HR (1) HRP940411B1 (de)
HU (1) HU222439B1 (de)
IL (1) IL110366A (de)
IS (1) IS4190A (de)
MY (1) MY118638A (de)
NO (1) NO313288B1 (de)
NZ (1) NZ271075A (de)
PE (1) PE8295A1 (de)
PL (1) PL175609B1 (de)
RU (1) RU2135485C1 (de)
SI (1) SI0710230T1 (de)
SV (1) SV1994000031A (de)
TW (1) TW290542B (de)
WO (1) WO1995003285A1 (de)
ZA (1) ZA945238B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5739129A (en) * 1994-04-14 1998-04-14 Glaxo Wellcome Inc. CCK or gastrin modulating 5-heterocyclic-1, 5 benzodiazepines
PE27497A1 (es) * 1994-04-15 1997-08-07 Glaxo Inc Derivados de 1,5 benzodiazepina
WO1998002419A1 (fr) * 1996-07-12 1998-01-22 Chugai Seiyaku Kabushiki Kaisha Inhibiteurs de proliferation de cellules cancereuses
US6683075B1 (en) 1996-12-23 2004-01-27 Athena Neurosciences, Inc. Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use
US6635632B1 (en) 1996-12-23 2003-10-21 Athena Neurosciences, Inc. Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
US20030190307A1 (en) 1996-12-24 2003-10-09 Biogen, Inc. Stable liquid interferon formulations
US6958330B1 (en) 1998-06-22 2005-10-25 Elan Pharmaceuticals, Inc. Polycyclic α-amino-ε-caprolactams and related compounds
US6569851B1 (en) 1998-06-22 2003-05-27 Elan Pharmaceutials, Inc. Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
TR200201026T2 (tr) 1999-10-15 2002-08-21 F.Hoffmann-La Roche Ag Benzodiazepin türevleri
US20050192265A1 (en) * 2003-03-20 2005-09-01 Thompson Richard C. Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
CA2813136A1 (en) * 2004-02-27 2005-09-15 Aortx, Inc. Prosthetic heart valve delivery systems and methods
EP2137167B1 (de) * 2007-04-19 2011-08-10 F. Hoffmann-La Roche AG Dihydro-benzo[b][1,4]diazepin-2-on-sulfonamidderivate
RU2540464C2 (ru) * 2012-05-28 2015-02-10 Государственное бюджетное образовательное учреждение высшего профессионального образования "Волгоградский государственный медицинский университет" Министерства здравоохранения и социального развития Российской Федерации Водорастворимое производное амида салициловой кислоты, обладающее транквилизирующей, ноотропной и анальгезирующей активностью
CN103435562B (zh) * 2013-08-26 2016-02-24 华东理工大学 6-取代苯并二氮卓-2,4-二酮类化合物及其用途
RU2702359C1 (ru) * 2019-06-04 2019-10-08 Федеральное государственное бюджетное научное учреждение Уфимский федеральный исследовательский центр Российской академии наук Способ получения 2,2,4-триалкил-2,3-дигидро-1Н-1,5-бензодиазепинов

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2641280B1 (fr) * 1988-12-29 1994-01-21 Roussel Uclaf Nouveaux derives de la 2,4-dioxo 2,3,4,5-tetrahydro 1h-1,5-benzodiazepine, leur procede de preparation et leur application comme medicaments
CA2068355A1 (en) * 1991-05-14 1992-11-15 Mark S. Chambers Benzodiazephine derivatives, compositions containing them and their use in therapy
GEP20001968B (en) * 1992-01-21 2000-03-05 Glaxo Spa Arilthio Compounds as Antibacterial and Antiviral Agents
GB9201181D0 (en) * 1992-01-21 1992-03-11 Glaxo Spa Chemical compounds
GB9225492D0 (en) * 1992-12-05 1993-01-27 Glaxo Group Ltd Amine derivatives

Also Published As

Publication number Publication date
ATE171167T1 (de) 1998-10-15
AP9400657A0 (en) 1994-07-31
US5716953A (en) 1998-02-10
DE69413405D1 (de) 1998-10-22
JPH09502428A (ja) 1997-03-11
AU7458994A (en) 1995-02-20
FI960223A0 (fi) 1996-01-17
ECSP941120A (es) 1995-01-16
PL175609B1 (pl) 1999-01-29
GB9314981D0 (en) 1993-09-01
NO313288B1 (no) 2002-09-09
HU222439B1 (hu) 2003-07-28
NZ271075A (en) 1998-06-26
DE69413405T2 (de) 1999-04-15
IL110366A (en) 1999-01-26
ES2123812T3 (es) 1999-01-16
AP492A (en) 1996-05-13
CN1138853A (zh) 1996-12-25
ZA945238B (en) 1995-02-09
HU9600124D0 (en) 1996-03-28
TW290542B (de) 1996-11-11
EP0710230B1 (de) 1998-09-16
IL110366A0 (en) 1994-10-21
RU2135485C1 (ru) 1999-08-27
CA2167308A1 (en) 1995-02-02
KR100347287B1 (ko) 2002-12-06
PL312659A1 (en) 1996-04-29
SI0710230T1 (en) 1999-02-28
CO4290299A1 (es) 1996-04-17
PE8295A1 (es) 1995-04-20
MY118638A (en) 2004-12-31
CZ290472B6 (cs) 2002-07-17
AU687858B2 (en) 1998-03-05
DK0710230T3 (da) 1999-06-14
EP0710230A1 (de) 1996-05-08
WO1995003285A1 (en) 1995-02-02
HRP940411A2 (en) 1997-04-30
JP3587849B2 (ja) 2004-11-10
IS4190A (is) 1995-01-21
FI960223A (fi) 1996-03-19
HUT73499A (en) 1996-08-28
CN1050835C (zh) 2000-03-29
CZ17396A3 (en) 1996-07-17
NO960237D0 (no) 1996-01-19
NO960237L (no) 1996-03-19
SV1994000031A (es) 1995-10-04

Similar Documents

Publication Publication Date Title
HU9402150D0 (en) 1,5-benzodiazepine derivatives
ZA942571B (en) 1,5 benzodiazepine derivatives
DE59403259D1 (en) Tetraaroxyperylen-3,4,9,10-tetracarbonsäurepolyimide
IL141908A (en) 1,4-benzodiazepine derivatives
GR3029455T3 (en) 3-Aryl-4-hydroxy-3-dihydrofuranone derivatives.
AP9400613A0 (en) 2,6-diaminopurine derivatives
ZA941137B (en) Substitutet azolone derivatives.
GR3030863T3 (en) 2',5'-oligoadenylate-2',3'-cyclophosphates
PL312659A1 (en) 1,5-benzodiazepine derivatives
AP9500731A0 (en) 1,5 benzodiazepine derivatives
ZA946569B (en) 1,5-Diphenyl-3-pyrazolylalkyl-N-hydroxydithiocarbamates
EP0710107A4 (de) N,n,n-trimethylsphingosin-derivate
HRP970186B1 (en) Novel 2,3-benzodiazepine derivatives
HU9301651D0 (en) Pyridyl-1,2,5-oxadiazole-carbonamide-2-oxide derivatives
HRP970162A2 (en) 1,25-dihydroxy-16,22,23-trisdehydro-cholecalciferol derivatives
HU9402534D0 (en) New naphtoxazine derivatives
IL110556A0 (en) 7 alpha-amino-1, 1-dioxocephem l- valylamides
ZA948311B (en) 1,2-dihydro-2-oxo-pyridines
HU9402902D0 (en) 1,2-dihydro-2-oxo-3-methyl-sulfonyl-aminomethyl-pyridine derivatives
EP0683787A1 (de) 4'-0-sulfonylanthracyclinderivate.
HU9501251D0 (en) 17,20-epoxy-20-substituted-pregnane derivatives
ZA941763B (en) Carpaine derivatives.
GB9406037D0 (en) 1,5 Benzodiazepine derivatives
ZA953056B (en) 1,5 benzodiazepine derivatives
GB9303982D0 (en) Substituted 1,1,2 triphenylbutenes

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20050706

Year of fee payment: 12

PBON Lapse due to non-payment of renewal fee

Effective date: 20060719